cabio biotech(wuhan) announced on December 2 that, as of November 30, 2024, the company has not repurchased its own shares through the special securities account for repurchase.
嘉必优(688089.SH)：尚未通过回购专用证券账户回购公司股份
Cabio Biotech (Wuhan) (688089.SH): has not repurchased company shares through the repurchase dedicated securities account
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated